14-16 November 2018


Who Attends?

Meet The Leading Minds In The Neoantigen Space

The Neoantigen Summit brings together the pioneers supercharging immunotherapy and vaccine development to share key clinical data and insights from sample acquisition, all the way through to vaccine manufacturing and getting a product to market.

Receive clinical updates on current programs, regulations for individualized products and scaling down manufacture for personalized therapeutics.

Who Will  You Meet?

As the only event to focus exclusively on neoantigen-based therapeutic development, our audience comprises of 62% decision-makers: VPs, Directors and C-Level Executives. Drug developers and academic institutions make up 81% of the room. So at the Neoantigen Summit you’re sure to meet the leading minds in this rapidly advancing space.

Who Meet Seniority

2017 Attendees Included:

Attendees 2017